Want to join the conversation?
On Sept. 14, 2015, $MYL announced the initiation of the Phase 3 program in the US supporting the registrational development program of TD-4208. In addition to this, $MYL made a $30MM investment in Theravance Biopharma's common stock during 1Q15. $MYL incurred $15MM in upfront development costs during the nine months ended Sept. 30, 2015.
Any idea why some investors are happy about the disastrous $UA results??
Wow! GM killed it with earnings today! Did not expect this after $F gave the feeling it will eclipse the Chevy maker completely!
Oil rebound starting to show up in energy stocks. $XOM $CVX
I have a feeling "CLOUDy" days are ahead, with $AMZN leading the pack.
$AAL is giving pay hikes to its employees but investors are sulking.